openPR Logo
Press release

United States Single-Use Bioprocessing Products Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

11-18-2025 11:21 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Single-Use Bioprocessing Products Market

Single-Use Bioprocessing Products Market

Market Size and Growth

The Global Single-Use Bioprocessing Products Market size was valued at USD 9200 million in 2022 and is estimated to reach USD 36000 million by 2031, growing at a CAGR of 18.6% during the forecast period (2024-2031).

Key Development:

United States: Recent Single‐Use Bioprocessing Developments

✅ In October 2025, Thermo Fisher showcased the 5 L DynaDrive SUB at CPhI, highlighting its unified design across scales and sustainability benefits via biobased film.

✅ In September 2025, Thermo Fisher Scientific completed its acquisition of Solventum's Purification & Filtration business (approx $4.0 bn), significantly bolstering its filtration capabilities across upstream and downstream bioprocessing workflows

✅ In June 2025, technical data showed that the 5 L DynaDrive SUB can reduce process‐development timelines by ~20% and boost lab throughput by up to ~30% compared to traditional glass bioreactors.

✅ In April 2025, Thermo Fisher Scientific introduced its 5 L DynaDrive Single‐Use Bioreactor, designed for seamless scale-up from 1 L to 5,000 L and enhanced productivity with lower environmental impact.

Japan: Recent Single‐Use Bioprocessing Developments

✅ In September 2025, the Thermo Fisher-Solventum deal secured antitrust / FDI clearance in Japan, among other jurisdictions, underscoring regulatory alignment for bioprocessing consolidation.

✅ In April 2025, AGC Biologics announced the addition of two 5,000 L Thermo Scientific DynaDrive single‐use bioreactors at its new Yokohama GMP facility, expected to start commercial operations by 2027.

✅ In April 2025, AGC Biologics revealed a ¥50 billion (approx USD 350 M) investment for its Yokohama site, which will house large-scale single-use bioreactor capacity for mammalian expression, mRNA, and cell therapies.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/single-use-bioprocessing-products-market?sb

Key Players:

=> Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corp., Merck KGaA, Avantor, Inc., 3M, Eppendorf AG, Saint-Gobain Biopharm, Progenics Pharmaceuticals, Gore and more.

Growth Drivers of Single-Use Bioprocessing Products:

✅ Rising demand for biologics and monoclonal antibodies driving adoption of single-use systems.

✅ Advantages such as reduced contamination risk, lower capital costs, and faster production cycles fueling growth.

✅ Advancements in disposable bioreactors, mixers, and filtration technologies improving process efficiency.

✅ Increasing biopharmaceutical manufacturing and contract manufacturing organization (CMO) expansions.

✅ Growing focus on flexible, scalable, and cost-effective manufacturing solutions in bioprocessing.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=single-use-bioprocessing-products-market

Key Segments:

By Product

Single-use bioreactors (SUBs) lead with 28% share, driven by their scalability, efficiency, and increasing adoption in biopharmaceutical production. Tubing, connectors, and clamps collectively account for 22%, supporting fluid transfer and process integrity in bioprocessing operations. Disposable mixers and bags hold 12%, while containers and disposable filter cartridges represent 10% and 8%, respectively, reflecting growing demand for flexible, contamination-free processing. Sampling systems and tangential flow filtration each hold 5%, membrane adsorbers 4%, purification devices 3%, preassembled tubing and rigging 2%, and other products make up 1%, catering to specialized bioprocessing needs.

By Application

Filtration dominates with 25% share, driven by regulatory requirements and demand for high-purity biologics. Storage accounts for 20%, supported by single-use storage bags and containers for intermediate and final products. Cell culture applications hold 18%, reflecting the rising adoption of SUBs in cell-based therapies. Mixing represents 15%, purification 12%, and other applications 10%, encompassing research, diagnostics, and small-scale production processes.

By End-User

Biopharmaceutical manufacturers lead with 60% share, driven by large-scale biologics production, increasing outsourcing of processes, and adoption of single-use technologies. Life science R&D companies and academic research institutes account for 30%, using disposable systems for experimental and pilot-scale research. Other end-users represent 10%, including contract development and manufacturing organizations (CDMOs) and specialized biotech firms.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/single-use-bioprocessing-products-market?sb

By Region

North America - 38% Share
North America leads with 38%, fueled by advanced biopharmaceutical infrastructure, early adoption of single-use technologies, and strong presence of key market players. Regulatory support and investment in cell and gene therapies further drive growth.

Europe - 27% Share
Europe holds 27%, supported by rising biologics production, stringent quality standards, and adoption of flexible manufacturing processes across major pharmaceutical hubs.

Asia Pacific - 23% Share
Asia Pacific accounts for 23%, driven by growing biopharmaceutical manufacturing in China, India, and Japan, and increasing investment in biologics and vaccine production facilities.

Latin America - 6% Share
Latin America holds 6%, supported by expanding biologics manufacturing and adoption of cost-efficient, disposable bioprocessing solutions.

Middle East - 3% Share
The Middle East represents 3%, fueled by emerging biotech sectors, vaccine production initiatives, and healthcare infrastructure expansion.

Africa - 3% Share
Africa accounts for 3%, driven by nascent biologics production, increasing research initiatives, and gradual adoption of single-use technologies in pharmaceutical and biotech manufacturing.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Single-Use Bioprocessing Products Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities here

News-ID: 4275601 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Immunohistochemistry Market 2026 | Growth Drivers, Trends & Market …
Market Size and Growth The Global Immunohistochemistry Market size was valued at US$ 2,302.79 million in 2022 and is estimated to reach US$4,240.65 million by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/immunohistochemistry-market?sb Key Development: United States: Recent Industry Developments ✅ In February 2026, the U.S. Food and Drug Administration approved PD‐L1 IHC 22C3 pharmDx
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads with 35% Share | Key Players: Albemarle Corporation, China Northern Rare Earth, MP Materials
Critical Minerals Market to Reach US$ 586.63 Billion by 2032; Asia Pacific Leads …
Market Overview Market Size (2024): USD 328.19 billion Expected Market Size (2032): USD 586.63 billion CAGR (2025-2032): 7.53% The global critical minerals market is experiencing unprecedented growth, driven primarily by the accelerating transition to clean energy technologies. Key energy transition minerals including lithium, cobalt, and nickel have seen rapid demand growth: lithium demand has tripled, cobalt demand has risen by 70%, and nickel demand has increased by 40% between 2017 and 2022. Clean energy
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America Leads with 40% Share | Key Players: Siemens Healthcare, Thermo Fisher Scientific, Abbott
Drug of Abuse Testing Market to Reach US$ 12.31 Billion by 2033; North America L …
Market Overview Market Size (2023): USD 7.26 billion Expected Market Size (2033): USD 12.31 billion CAGR (2025-2033): 5.3% Drug abuse testing is a critical process for detecting prescription and illicit substances in an individual's system, ensuring safety, regulatory compliance, and medical evaluation. It is widely used across workplace screening, forensic investigations, sports anti-doping programs, and clinical diagnostics. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/drug-of-abuse-testing-market?Juli Advancements in rapid detection
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Aesthetic Lasers and Energy Devices Market 2026 | Growth Drivers, …
Market Size and Growth Aesthetic Lasers and Energy Devices Market is estimated to reach at a CAGR of 6.40% during the forecast period (2024-2031). Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/aesthetic-lasers-and-energy-devices-market?sb Key Development: United States: Recent Industry Developments ✅ In November 2025, Venus Concept Inc. secured FDA 510(k) clearance for its Venus NOVATM platform, a next‐generation multi‐application device combining radiofrequency, EMS, and electromagnetic technologies for non‐invasive

All 5 Releases


More Releases for Bioprocessing

Bioprocessing Market Size, Demand, and Forecast | 2031
Global Bioprocessing Market Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00039016?utm_source=OpenPR&utm_medium=10855 Key Players Analysis: • Getinge AB, • Thermo Fisher Scientific Inc, • Sartorius AG, • Corning Inc, • Bio-Rad Laboratories Inc. • Merck KGaA, • 3M Co, • Eppendorf SE, • Repligen Corp, • Entegris Inc, The report covers key developments in the Bioprocessing Market as organic and inorganic growth strategies. Various companies are focusing on
Global Single-Use Downstream Bioprocessing Market
According to a new market research report published by Global Market Estimates, the Global Single-Use Downstream Bioprocessing Market is projected to grow at a CAGR of 21.5% from 2023 to 2028. Sartorius AG, 3M Purification, Danaher (Cytiva), Repligen Corporation, Merck Millipore, Sepragen Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, INC., Dr. Mueller AG, Parker Hannifin Corp, Agilitech, and Foxx Life Sciences., among others, are some of the key players in
Bioprocessing Reagents Market Latest Advancements 2023-2028
A novel report on "Global Bioprocessing Reagents market Size, Share, Trends and Opportunities, Forecast to 2028" has been added to Xcellent Insights' database to help users, stakeholders gain precise insights on global Bioprocessing Reagents industry. The report offers estimates for market share, revenue CAGR, market consumption, production, and gross profit margin. It also sheds light on market segmentation, regional analysis and top companies operating in the market. Our analysts and
Global Single-use Upstream Bioprocessing Market
According to a new market research report published by Global Market Estimates, the Global Single-use Upstream Bioprocessing Market is projected to grow from USD 8.1 Billion in 2022 to USD 24.8 Billion by 2027 at a CAGR value of 15.5% from 2022 to 2027. Danaher Corporation (Cytiva), Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Pall Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Rentschler Biopharma SE, Lonza, Meissner
Global Bioprocessing Bags Market Report- Forecast 2026
According to a new market research report published by Global Market Estimates, the Global Bioprocessing Bags Market is projected to grow from USD 8.5 billion in 2021 to USD 21.1 billion by 2026 at a CAGR value of 20.7% from 2021 to 2026. The bioprocessing bag market is being driven by factors such as increasing demand for pharmaceuticals and energy consumption; rising need to minimize wastage of water, increasing flooring
Single-use Bioprocessing Market 2022 | Detailed Report
The Single-use Bioprocessing research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,